We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXAS
276
DELISTED
Exact Sciences
EXAS
$1.68M 0.05%
12,666
+6,750
+114% +$816K
TNA icon
277
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.47B
$1.68M 0.05%
25,300
-49,973
-66% -$2.43M
BIIB icon
278
Biogen
BIIB
$30.7B
$1.68M 0.05%
6,843
-612
-8% -$158K
APD icon
279
Air Products & Chemicals
APD
$67.6B
$1.67M 0.05%
6,123
-973
-14% -$274K
VFC icon
280
VF Corp
VFC
$5.89B
$1.67M 0.05%
19,509
+13,373
+218% +$1.07M
CZR icon
281
Caesars Entertainment
CZR
$6.14B
$1.67M 0.05%
22,422
-51,421
-70% -$3.22M
IDA icon
282
Idacorp
IDA
$8.2B
$1.66M 0.05%
17,296
+2,099
+14% +$191K
EQR icon
283
Equity Residential
EQR
$25.1B
$1.65M 0.05%
27,880
+4,150
+17% +$234K
IOVA icon
284
Iovance Biotherapeutics
IOVA
$2.87B
$1.64M 0.05%
35,380
+31,705
+863% +$1.26M
LRCX icon
285
Lam Research
LRCX
$390B
$1.64M 0.05%
34,760
-59,330
-63% -$2.5M
Y
286
DELISTED
Alleghany Corp
Y
$1.64M 0.05%
2,715
-1,113
-29% -$649K
REGN icon
287
Regeneron Pharmaceuticals
REGN
$80.8B
$1.64M 0.05%
3,387
-1,478
-30% -$798K
ADSK icon
288
Autodesk
ADSK
$52.6B
$1.63M 0.05%
5,347
-3,354
-39% -$884K
WTW icon
289
Willis Towers Watson
WTW
$32B
$1.63M 0.05%
7,729
-1,629
-17% -$335K
IJS icon
290
iShares S&P Small-Cap 600 Value ETF
IJS
$8.37B
$1.62M 0.05%
19,973
-69,509
-78% -$5.05M
IYW icon
291
iShares US Technology ETF
IYW
$25.5B
$1.62M 0.05%
19,089
-76,635
-80% -$6.12M
NSC icon
292
Norfolk Southern
NSC
$75.1B
$1.62M 0.05%
6,832
+979
+17% +$223K
HAE icon
293
Haemonetics
HAE
$4B
$1.62M 0.05%
13,645
-14,146
-51% -$1.52M
PEN icon
294
Penumbra
PEN
$12.8B
$1.62M 0.05%
9,250
-3,281
-26% -$719K
CRL icon
295
Charles River Laboratories
CRL
$12.8B
$1.61M 0.05%
6,456
-4,678
-42% -$1.11M
FCN icon
296
FTI Consulting
FCN
$4.18B
$1.61M 0.05%
14,398
-3,729
-21% -$402K
UYG icon
297
ProShares Ultra Financials
UYG
$845M
$1.61M 0.05%
37,969
+28,962
+322% +$1.05M
CGNX icon
298
Cognex
CGNX
$11.3B
$1.6M 0.05%
19,977
-16,173
-45% -$1.18M
UBER icon
299
Uber
UBER
$153B
$1.6M 0.05%
31,466
+30,274
+2,540% +$1.36M
PTC icon
300
PTC
PTC
$16B
$1.6M 0.05%
13,388
-11,353
-46% -$1.13M

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.